David Meek

Track

Insider profile

Currently holds positions in Baxalta Inc and Uniqure NV

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, President - Oncology Baxalta Inc None -
Non-Executive Independent Director Uniqure NV None -
Chief Executive Officer, Director Ipsen SA June 7, 2017 - Dec. 31, 2019
Chief Executive Officer Ipsen SA July 18, 2016 - June 7, 2017
Chief Commercial Officer Endocyte Inc Aug. 1, 2012 - June 2, 2014
David Meek's trades of Ipsen SA's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
FR Ipsen SA (IPN)
Transaction date
Sale
Price
357.11
Quantity 5,325
Value €3,236,222
FR Ipsen SA (IPN)
Transaction date
Sale
Price
36.71
Quantity 34,263
Value €392,680
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2019-06-10 2019-06-06
FR Ipsen SA (IPN)
S Sale
5,325
357.11
€3,236,222 		5,325 357.11 €3,236,222
2018-08-28 2018-08-27
FR Ipsen SA (IPN)
S Sale
34,263
36.71
€392,680 		34,263 36.71 €392,680